Tai­ho antes up an ex­tra $250M for its ven­ture arm as it gets se­ri­ous about 'glob­al on­col­o­gy' deals

Japan’s Tai­ho Phar­ma has been scout­ing the globe for in­no­va­tions to com­ple­ment its on­col­o­gy drug dis­cov­ery pipeline — and it now ap­pears ready to spend on …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.